mAbxience2024-05-13T17:30:25+02:00

BIOPHARMACEUTICAL DEVELOPMENT

Experts in biologics, specialized in biosimilars

We are a leading vertically integrated biopharmaceuticals company, committed to improving patient access to treatments worldwide. Our in-house, core R&D competencies set us apart in the development of biosimilars and innovator biologics.

CDMO PLATFORM

End-to-end solutions to meet any manufacturing need

Thanks to our independent CDMO platform, we provide integrated services, adapted to your requirements: from research batches to commercial batches, big or small. We have over a decade of experience in the development and commercialization of biopharmaceuticals.

JOIN US!

Do you want to work at mAbxience?

WHAT’S NEW?

Catch up with our latest developments

Advancements in Custom Biopharmaceutical Development

Advancements in Custom Biopharmaceutical Development

News|

Accelerating Biologics Development: mAbxience’s “Gene to Biologics Drug Substance (BDS) in 12 Months” Program

Accelerating Biologics Development: mAbxience’s “Gene to Biologics Drug Substance (BDS) in 12 Months” Program

News|

mAbxience Appoints Jurgen Van Broeck as New CEO

Go to Top